9/3
11:04 pm
abio
ARCA biopharma, Inc. (NASDAQ: ABIO) was upgraded by analysts at StockNews.com to a "sell" rating.
Neutral
Report
ARCA biopharma, Inc. (NASDAQ: ABIO) was upgraded by analysts at StockNews.com to a "sell" rating.
9/2
09:23 am
abio
Upcoming Stock Splits This Week (September 2 to September 6) – Stay Invested [Yahoo! Finance]
Neutral
Report
Upcoming Stock Splits This Week (September 2 to September 6) – Stay Invested [Yahoo! Finance]
8/29
04:54 pm
abio
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split [Yahoo! Finance]
Medium
Report
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split [Yahoo! Finance]
8/29
04:50 pm
abio
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
Low
Report
ARCA biopharma Announces Completion of Merger with Oruka Therapeutics and Implementation of Reverse Stock Split
8/26
07:30 pm
abio
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
Medium
Report
ARCA biopharma Provides Update Regarding Special Dividend Amount in Connection with the Proposed Merger with Oruka Therapeutics
8/23
04:30 pm
abio
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics
Medium
Report
ARCA biopharma Announces 1-for-12 Reverse Stock Split in Connection with the Proposed Merger with Oruka Therapeutics